Roche Makes Obesity Splash, Moderna Cans Vaccine Trials, Sarepta’s New Data, More
Roche made the biggest splash this week so far, announcing on Tuesday that GLP-1/GIP injectable CT-388 led to 22.5%weight loss in a Phase II trial. These numbers appear to put CT-388, which Roche acquired in its $2.7 billion Carmot buy, in line with Eli Lilly’s Zepbound, according to William Blair …
THE ANDREA KAYE SHOW | 01.11.23 HOUR 1
Guest this hour: Daniel Greenfield, journalist and writer at "Front Page Mag" http://www.FrontPageMag.com and Sultan Knish Blog!
A.K. opens the hour about MORE documents discovered to have been taken in multiple locations from former VICE president Biden. Daniel Greenfield joins the show to go o…
mRNA horizon
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
https://news.modernatx.com/news/news-details/2024/Moderna-Receives-U.S.-FDA-Approval-for-RSV-Vaccine-mRESVIAR/default.aspx
May 31, 2024
Moderna, today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mR…
Stéphane Bancel: The 5% Bet That Built Moderna
In 2011, Stéphane Bancel walked away from the security of leading a 6,000-person diagnostics company to join a startup of about 50 people, built on an idea most scientists had dismissed: that messenger RNA could become medicine. Almost everyone told him not to do it. He gave the bet roughly a five …
More Human Than Ever: Summer Special 2026
Every August, I offer you something different. Not a new conversation, but a pause.
This was the year AI stopped being a headline and became part of our daily lives as leaders. I dedicated a whole series to it, from robotics to education to medicine to trust. And one paradox kept coming back, conv…
Moderna CEO Stéphane Bancel on the Next Era of mRNA
a16z General Partner Jorge Conde sits down with Moderna CEO Stéphane Bancel to discuss a major milestone for mRNA technology: positive Phase 3 results from Moderna and Merck’s individualized treatment for melanoma, after more than a decade of work on personalized cancer vaccines.
Stéphane explains…
Episode 21 | I Shouldn't Be Here: Moderna's First CSO on Making Life Count (Antonin de Fougerolles)
Tony de Fougerolles was born in Montreal three months premature, weighing about a pound and a half. He was the youngest child in Canada to survive at that age and weight. Twenty years of operations followed: doctors two or three times a week, surgery every summer, every Christmas. Ask him what he w…
Curing Cancer Could Be Close
Stéphane Bancel has been CEO of Moderna since 2011, but it’s almost as if he's led three different companies in the past five years.
First came the pandemic sprint: A biotech with no commercial products became a household name, manufacturing a billion vaccine doses in 2021 and generating roughly $…
Weekend Update - W2643
▶ Explore this week’s Tape — live, sortable, drill-down →
The Tape — W2643
Universe of 94 cashflow-memo names, snap dates 2026-10-17 → 2026-10-23. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.
Telltales …
Moderna CEO Stéphane Bancel Talks Vaccine Collaboration With Merck
Stéphane Bancel, Moderna CEO, said in an interview with Bloomberg's Romaine Bostick, that he believes the personalized mRNA cancer vaccine his company is developing with Merck & Co. will work in a variety of tumors, directly addressing a key issue shrouding the company’s future.
See omnystudio.com…
PODCAST SEARCH ENGINE
You can use our website to search 3,828,924 podcasts and 196,512,736 episodes by people, places, or topics.
An investment in knowledge pays the best interest, so I listen to podcasts.
‐ Benjamin "Llamacorn" Franklin
EDIT
Thank you for helping to keep the podcast database up to date.
